Why this resource exists
Is Ibogaine Dangerous was created because people researching ibogaine told us they wanted clear, independent information that separates what is known from what is uncertain. Our mission is concise: Is Ibogaine Dangerous is a new independent information company helping people researching ibogaine make sense of ibogaine, focused on evidence, safety, legality and practical questions about ibogaine.
Many readers arrive via practical queries about administration and safety; when that is relevant on the site we link to specialist pages such as the procedural overview at how ibogaine is administered, which we reference in context to illustrate how different content types complement our editorial guides.
Our editorial approach
We organize content as concise guides, a featured safety primer, focused checklists, and service-oriented pages so readers can move from high-level summaries to practical detail without wading through promotional content.
To support those statements we rely on primary research sources and established reference materials. For example, when we describe editorial vetting we consult standard literature registries and broadly accepted clinical summaries such as the treatment overview on Wikipedia’s ibogaine article for historical context, and authoritative guidance on clinical safety practices available from major institutions like the U.S. National Institutes of Health when discussing how evidence is evaluated.
What we cover
We produce explanatory pages that emphasize: evidence summaries, safety considerations, legal context, and practical questions readers commonly raise. Content is organized into categories and featured guides so readers can find quick answers or dig into the source material.
How information is sourced and vetted
We do not rely on a single source. Our factbase is built from peer-reviewed literature, clinical registries, public health documents, and primary legal texts. That evidence is summarized in plain language and linked back to original sources when possible so readers can verify claims themselves.
To illustrate how we use external material: systematic reviews and indexed trials in PubMed often guide our summaries of evidence strength, and when referencing legal frameworks we consult primary government publications such as legislation or regulatory agency pages rather than secondary summaries (U.S. National Library of Medicine is an example of an authoritative registry we consult for clinical indexing).
Who this is for
This site is written for people researching ibogaine: those seeking to understand the evidence, potential harms, legal considerations, and practical questions. We do not offer clinical services or treatment advice; readers should consult licensed healthcare professionals for personal medical decisions.
Editorial principles
-
IndependenceWe publish without commercial clinic endorsements or paid treatment referrals.
-
Evidence-firstClaims are tied to primary literature or official sources; uncertainty is stated plainly.
-
Audience-focusedContent is written for people researching ibogaine rather than clinicians or marketers.
-
Transparent sourcingWhere possible we link to the original study, review, or official page behind a claim.
Independent by design
Is Ibogaine Dangerous is an independent information resource. It is not a clinic, medical provider, or licensed treatment center, and its content is not medical or legal advice.